Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.
A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...
Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...
Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...
In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...
A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...
Stocktwits on MSN
Anavex Retail Traders See Silver Lining In EMA Committee Postpones Alzheimer’s Drug Verdict: Delay 'Actually A Positive Sign'
The CHMP issued a negative trend vote but postponed its final decision to December. ・Retail traders were divided, citing ...
A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. Two other medicines, to treat erectile dysfunction and motor neurone disease, also showed strong potential.
Alzheimer’s drug donanemab approved for use by drug regulator, likely to be available in India next year ...
Eli Lilly receives CDSCO approval for donanemab, a new Alzheimer's treatment targeting early symptomatic stages of the ...
For decades, hormone replacement therapies carried warnings that they increased the risk of cancer and dementia. Now, that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback